AstraZeneca Pharma India gets DCGI nod to market cancer drug in India

New Delhi: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets used for the treatment of ovarian and breast cancer. The permission from the DCGI is for olaparib (Lynparza) tablets in the strengths of 100 mg and 150 mg, AstraZeneca Pharma India said in a BSE filing.

The tablets are a patented product of the AstraZeneca group, it added.

“The import and market permission for olaparib is a significant milestone for women in India living with platinum-sensitive relapsed ovarian cancer and BRCA-mutated HER-2 negative metastatic breast cancer, which has historically been difficulty-to-treat diseases,” AstraZeneca Pharma India MD Gagan Singh said.

Shares of AstraZeneca Pharma India today closed at Rs 1,710.30 per scrip on BSE, up 1.59 per cent from their previous close.

  • Related Posts

    Kerala researchers develop biosensor to measure snake venom for faster treatment

    Thiruvananthapuram: A biosensor that can measure the amount of venom injected into the body after a snakebite and help doctors administer the required dose of anti-venom has been developed by…

    Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

    Biophore India Pharmaceuticals chief executive officer Jagadish and chief strategy officer Manik Reddy Pullagurla each contributed ₹1 crore; TTD chairman B.R. Naidu received the demand drafts at his Tirumala Camp…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Kerala researchers develop biosensor to measure snake venom for faster treatment

    Kerala researchers develop biosensor to measure snake venom for faster treatment

    Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

    Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

    Pharma pricing policy threatens innovation

    Pharma pricing policy threatens innovation

    16 empanelled hospitals face action after negligence in Ayushman Scheme

    16 empanelled hospitals face action after negligence in Ayushman Scheme

    Hollywood fame Bollywood Babe Neetu Chandra emerges a Cancer Crusader worldwide

    Hollywood fame Bollywood Babe Neetu Chandra emerges a Cancer Crusader worldwide

    18 maternal deaths still a ‘mystery’, says Rajasthan health minister

    18 maternal deaths still a ‘mystery’, says Rajasthan health minister